[codegeek]

"and the pharma company actually felt a significant drain in revenue, they may decide not to license the manufacture of these drugs in India at lower prices"

But thats the thing. There will be no drain in revenue as they make money in the US by selling for $84K while they make money from the sales in India as well due to licensing agreement (albeit a bit less revenue).

Overall, still a pretty good deal for these pharma companies if you ask me otherwise why would they even do such a deal with India ?

[surrealvortex]

Well, my point was that if everyone decided to source it through India, they will no longer sell anything for $84k. Even if 10% of people did that, their profits will slip enough for them to notice and take action.